Plain-English translation of NCT06620380 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new approach called pharmacoscopy—a lab test that analyzes your tumor sample to identify which medications will work best against your specific cancer. Instead of guessing which treatment to try, doctors use real-time testing on your tumor cells to guide their choices. This approach has worked well in blood cancers and may help people with brain metastases get more effective personalized treatment.
Many people with brain metastases have limited treatment options, and doctors don't always know which medication will work best for each patient's specific tumor. This medication aims to solve that problem by using laboratory testing to predict which drugs will be most effective before you start treatment.
You likely qualify if…
You likely don't qualify if…
If you qualify and choose to participate, you will have surgery to remove the brain tumor as clinically indicated. During surgery, doctors will take a small sample of your tumor for pharmacoscopy testing. You will then be randomly assigned to either receive personalized treatment based on the laboratory test results, or standard treatment without the test. You will be followed by your medical team to monitor how well the treatment works and track any side effects over time.
AI-generated summary from trial data · Aug 2, 2026 · Not medical advice
Switzerland